ArticleBreast cancer research : BCR2023

METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.

Dengjie Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.